top of page

News & Updates

Explore by Category:   News   |   Press  

News, Press

|

May 15, 2026

T4GMH Announces New Co-Executive Directors

T4GMH Announces New Co-Executive Directors

Texans for Greater Mental Health has announced Vance McMurry and Mary Olivar as Co-Executive Directors, who will lead the organization’s next phase of growth, implementation, and statewide engagement.

News, Press

|

Apr 20, 2026

Executive Order Accelerates Psychedelic-Assisted Therapies

Executive Order Accelerates Psychedelic-Assisted Therapies

President Trump signs Executive Order accelerating psychedelic research and access, building on Texas-led efforts including HB 1802 and the Texas Ibogaine Initiative.

News

|

Dec 22, 2025

Logan Davidson Announces Executive Director Transition

Logan Davidson Announces Executive Director Transition

Logan Davidson announces his transition to Senior Advisor and Policy Director as the organization launches a national search for its next leader.

Press

|

Dec 12, 2025

Texas Awards $50M for Ibogaine Research

Texas Awards $50M for Ibogaine Research

Texas Ibogaine Initiative clinical trials consortium awarded. Texas announces a historic $50 million investment, advancing research for addiction, PTSD, and traumatic brain injury.

Press

|

Dec 2, 2025

Logan Davidson on Ibogaine & Psychedelic Policy

Logan Davidson on Ibogaine & Psychedelic Policy

In a Psychedelics Today interview, Logan Davidson, Executive Director of Texans for Greater Mental Health, discusses the evolving landscape of ibogaine in the U.S. and how state-led advocacy is shaping the future of psychedelic policy.

News

|

Jun 11, 2025

Governor Abbott Signs the Texas Ibogaine Initiative Into Law

Governor Abbott Signs the Texas Ibogaine Initiative Into Law

Governor Greg Abbott has signed SB 2308 into law, establishing the Texas Ibogaine Initiative and a historic $50 million state investment in ibogaine research.

News

|

May 28, 2025

The Texas Ibogaine Initiative (SB 2308) Passes the Texas Legislature

The Texas Ibogaine Initiative (SB 2308) Passes the Texas Legislature

The Texas Legislature passed SB 2308, a landmark bill establishing a $50 million investment in ibogaine research for opioid use disorder, PTSD, traumatic brain injury, and other conditions.

Sign Up & Stay Informed

Stay updated on groundbreaking psychedelic therapy legislation, upcoming events, and ways you can support mental health reform in Texas. Together, we can create real change.

Psychedelic policy reform
bottom of page